Tics are sudden, rapid, non-rhytmic, repetitive, motor movements or vocalizations. The mean age of onset is approximately 5 years old.
Tourette's syndrome is the most common form of tic disorder.
There is a strong genetic component showing a 10- to 100-fold increase in the rates of tics and Tourette's syndrome among first-degree relatives of Tourette's syndrome patients.
Simple motor tics are restricted to a single or a few muscle groups and last less than a fraction of a second.
Complex motor tics involve larger muscle groups, usually last longer and appear purposeful and goal-directed.

Tourette's%20syndrome%20-and-%20other%20tic%20disorders Treatment

Principles of Therapy

  • May be considered if symptoms interfere with normal functioning
  • Successful treatment of comorbid disorder usually decreases tic severity
  • There is no cure for Tourette syndrome (TS); aim of pharmacological therapy is to reduce the frequency and severity of tics
  • Goals should be to relieve tic-related discomfort/embarrassment and to allow the patient to function as normally as possible
  • Choice of treatment depends on the following factors: severity of symptoms, address the most problematic symptom(s), patient’s sense of urgency for treatment, and patient’s aversion to risk of likely or unlikely adverse effects


Alpha-Adrenergic Agents


  • May be preferred over antipsychotic medications because of decreased risk of acute and long-term side effects
  • Useful for children who are hyperactive, impulsive and disinhibited
  • Has been shown to improve tics and attention-deficit/hyperactivity disorder (ADHD) 


  • Found to be less sedating and less hypotensive than Clonidine
  • Has been shown to improve tics and attention-deficit/hyperactivity disorder
  • Ensures more patient compliance as it can be given once at bedtime or 2x daily as compared with 3-4x daily doses of Clonidine


  • Neuroleptics are considered the most effective drugs

Conventional/Typical Antipsychotics

  • Haloperidol
    • Side effects tend to limit use and there are other agents that may be better tolerated
    • Many case reports and placebo-controlled studies have shown effectiveness
  • Pimozide
    • Shown to be effective in Tourette syndrome (TS)
    • May be more effective than Haloperidol but studies comparing the 2 agents have been conflicting

Selective Dopamine D2 Receptor Antagonists

  • Sulpiride
    • A small number of uncontrolled studies have shown Sulpiride to be effective in treating tics in 59% of patients
    • Improves aggressive obsessive-compulsive behavior and mood
  • Tiapride
    • Small number of studies have shown that it reduces tics without affecting cognitive impairment
  • Tetrabenazine
    • Depletes dopamine by inhibiting vesicular monoamine transporter type 2
    • As effective as the typical neuroleptics but does not cause tardive dyskinesia
    • Studies have shown to be effective in hyperkinetic movement disorders

Atypical Antipsychotic

  • Aripiprazole 
    • Indicated for treatment of Tourette’s disorder in pediatric patients 6-18 years
    • Acts as antagonist at D2 receptors under hyperdopaminergic conditions and displays agonist properties under hypodopaminergic conditions
  • Risperidone
    • Extrapyramidal syndrome side effects are usually less compared with conventional antipsychotics
    • Most extensively studied of the atypical antipsychotics in the treatment of Tourette syndrome
    • Several studies show Risperidone is effective for Tourette syndrome
    • Has been advocated as 1st-line agent in patients with tics & obsessive-compulsive disorder symptoms
    • Based on a retrospective chart review, it has been shown to decrease aggressive behavior in patients with Tourette syndrome

Selective Serotonin Re-uptake Inhibitors (SSRIs)1

  • Considered 1st-line agents in patients with significant depression or obsessive-compulsive disorder symptoms
  • May improve tics in some patients, may worsen them, or may have no effect on tics in others
  • Eg Fluoxetine

Selective Noradrenaline Reuptake Inhibitor (SNRI)

  • Atomoxetine
    • A nonstimulant found to be modestly effective in the treatment of Tourette syndrome-related attention-deficit/hyperactivity disorder (ADHD)

Tricyclic Antidepressant1

  • Clomipramine
    • Has nonselective reuptake blocking properties that relieve symptoms of obsessive-compulsive disorder (OCD) 


  • Considered 1st-line agents in patients with attention-deficit/hyperactivity disorder
  • Methylphenidate may be better tolerated than Dextroamphetamine in patients with Tourette Syndrome
  • Methylphenidate and Clonidine have additive benefits in Tourette syndrome and attention-deficit/hyperactivity disorder

Botulinum Toxin

  • Involves local intramuscular (IM) injection of the toxin to the affected muscle site
  • Most useful for persistent, focal motor (eg eye blinking, neck and shoulder tics), and sometimes vocal tics by temporarily weakening the affected muscles
  • Tic and tic urges have been shown to improve
  • Effects can be seen in the absence of gross weakness
  • Lasts for only 12-16 weeks

Other Agents Reported to Improve Tics

  • Topiramate
    • Alternative agent in patients with mild but troublesome tics who are intolerant or unresponsive to other treatment agents
    • More studies are needed to confirm safety and efficacy
  • Baclofen, Clonazepam, Fluphenazine, Levetiracetam, Lithium, Naloxone, Nicotine, Olanzapine, Quetiapine, Talipexole, Ziprasidone

1Please refer to Obsessive-Compulsive Disorder Management Chart for detailed discussion on treatment.

2Please refer to Attention Deficit/Hyperactivity Disorder Management Chart for detailed discussion on treatment

Non-Pharmacological Therapy

Behavioral Treatment

  • Individualized, specifically based on the needs of the patient
  • May be a treatment option for patients who prefer non-pharmacological treatment or patients intolerant or unresponsive to pharmacological therapy
  • Most disabling symptoms should be targeted first
  • Interventions which have been used in the treatment of tics:
    • Cognitive therapy 
      • Recommended as 1st-line treatment for patients with tic disorders and obsessive-compulsive disorder (OCD)
    • Habit-reversal training consists of tic-awareness training and competing-response training
      • May be effective in improving tics and controlling symptoms in Tourette syndrome (TS) based on findings from unblinded trials and a controlled trial with blinded outcome assessment
    • Massed negative practice
    • Assertiveness training
    • Relaxation therapy
    • Awareness training (including self-monitoring)
  • Comprehensive Behavioral Intervention for Tics (CBIT) composed of habit reversal training, relaxation training and functional interventions addressing situations which sustain or worsen tics is a recommended treatment option for patients with tics

Deep Brain Stimulation

  • An invasive neurosurgical procedure reserved for severe refractory cases of Tourette syndrome
  • Considered to be an experimental option for intractable cases
  • The largest published trial showed a mean reduction of 29% in the YGTSS

Exposure & Response Prevention

  • Patients who have in a prolonged period of time with unpleasant premonitory sensations (exposure) and resisting the tic (response prevention), the patients may learn to tolerate the unpleasant sensation (habituation)
    • Habituation will lessen the urge or need to give into the tic, resulting in the reduction of tic behavior
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Saras Ramiya, 16 Jan 2020

The Malaysian Psychiatric Association (MPA), Malaysian Mental Health Association (MMHA) and Pfizer Malaysia jointly launched a new mental health handbook in December 2019 to highlight the signs and symptoms of mental health issues and encourage Malaysians to see a doctor early if they experience any signs or symptoms.